1. Home
  2. QLGN
  3. QLGN News

Latest Qualigen Therapeutics Inc. (QLGN) News on January 19, 2025

QLGN

MT Newswires

a month ago

Qualigen Therapeutics Regains Compliance With Nasdaq's Minimum Bid Price, Equity Rules

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement
QLGN

GlobeNewswire

a month ago

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
QLGN

GlobeNewswire

2 months ago

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
QLGN

GlobeNewswire

2 months ago

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024
QLGN

GlobeNewswire

3 months ago

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024

Qualigen Therapeutics, Inc. Announces management changes.
QLGN

GlobeNewswire

4 months ago

Qualigen Therapeutics, Inc. Announces management changes.

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
QLGN

GlobeNewswire

4 months ago

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel

Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
QLGN

GlobeNewswire

4 months ago

Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering
QLGN

GlobeNewswire

4 months ago

Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering

QLGN

MT Newswires

4 months ago

Qualigen Therapeutics Shares Fall After $3.46 Million Public Offering Priced

Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering
QLGN

GlobeNewswire

4 months ago

Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering

Lifecore Biomedical Announces Cooperation Agreement with 22NW
QLGN

GlobeNewswire

7 months ago

Lifecore Biomedical Announces Cooperation Agreement with 22NW

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
QLGN

GOBankingRates

7 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller
QLGN

AFP

7 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up
QLGN

AFP

7 months ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge
QLGN

Bloomberg

7 months ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally
QLGN

AFP

7 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
QLGN

Business Insider

7 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
QLGN

Insider Monkey

7 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
QLGN

Reuters

7 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

QLGN

Journal-News, Hamilton, Ohio

7 months ago

Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now
QLGN

Motley Fool

7 months ago

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs
QLGN

TechCrunch

7 months ago

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

Italian energy company targets Britain for fleet of 20 mini-nukes
QLGN

The Telegraph

7 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
QLGN

Simply Wall St.

7 months ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Saudis Said to Hand About 60% of Aramco Offer to Foreigners
QLGN

Bloomberg

7 months ago

Saudis Said to Hand About 60% of Aramco Offer to Foreigners

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
QLGN

Simply Wall St.

7 months ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
QLGN

Simply Wall St.

7 months ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination
QLGN

GlobeNewswire

8 months ago

Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination

Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
QLGN

GlobeNewswire

9 months ago

Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™

Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
QLGN

GlobeNewswire

9 months ago

Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting

Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting
QLGN

GlobeNewswire

9 months ago

Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting

11 Best Wine Stocks to Buy Now
QLGN

Insider Monkey

a year ago

11 Best Wine Stocks to Buy Now

With 47% ownership, Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) has piqued the interest of institutional investors
QLGN

Simply Wall St.

a year ago

With 47% ownership, Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) has piqued the interest of institutional investors

QLGN

Newsfile

a year ago

LM Funding to Present at the Microcap Conference in Atlantic City

Green Brick Partners (GRBK) Posted a 114% Gain in 2023
QLGN

Insider Monkey

a year ago

Green Brick Partners (GRBK) Posted a 114% Gain in 2023

LM Funding America, Inc. Provides Quarterly Operational and Bitcoin Mining Update for Three Months Ended December 31, 2023
QLGN

GlobeNewswire

a year ago

LM Funding America, Inc. Provides Quarterly Operational and Bitcoin Mining Update for Three Months Ended December 31, 2023

Lisata Therapeutics Announces First Patient Treated in the Phase 2a Trial of LSTA1 in Patients with Glioblastoma Multiforme
QLGN

GlobeNewswire

a year ago

Lisata Therapeutics Announces First Patient Treated in the Phase 2a Trial of LSTA1 in Patients with Glioblastoma Multiforme

Quhuo to Hold 2023 Annual General Meeting on February 19, 2024
QLGN

PR Newswire

a year ago

Quhuo to Hold 2023 Annual General Meeting on February 19, 2024

Sidoti Events, LLC's Virtual January Micro-Cap Conference
QLGN

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease
QLGN

Business Wire

a year ago

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

Movella Holdings Inc. Announces Leadership Transition
QLGN

GlobeNewswire

a year ago

Movella Holdings Inc. Announces Leadership Transition

Is ACRES Commercial Realty (ACR) Outperforming Other Finance Stocks This Year?
QLGN

Zacks

a year ago

Is ACRES Commercial Realty (ACR) Outperforming Other Finance Stocks This Year?

Barnwell Industries, Inc. Announces Entry into Agreement for the Sale of Water Resources International, Inc. for Gross Proceeds of $2,000,000
QLGN

GlobeNewswire

a year ago

Barnwell Industries, Inc. Announces Entry into Agreement for the Sale of Water Resources International, Inc. for Gross Proceeds of $2,000,000

Wall Street Analysts Believe Orthofix (OFIX) Could Rally 72.19%: Here's is How to Trade
QLGN

Zacks

a year ago

Wall Street Analysts Believe Orthofix (OFIX) Could Rally 72.19%: Here's is How to Trade

ELEVAI Labs, Inc. Expands International Distribution into Europe
QLGN

GlobeNewswire

a year ago

ELEVAI Labs, Inc. Expands International Distribution into Europe

Iteris Introduces Multi-Level Cloud-Enabled Managed Services to Optimize Traffic Detection
QLGN

Business Wire

a year ago

Iteris Introduces Multi-Level Cloud-Enabled Managed Services to Optimize Traffic Detection

Zedge to Report First Fiscal Quarter 2024 Results
QLGN

ACCESSWIRE

a year ago

Zedge to Report First Fiscal Quarter 2024 Results

GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia
QLGN

GlobeNewswire

a year ago

GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia

QLGN

ACCESSWIRE

a year ago

Royalty Management Holding Co. Showcases Ferrox Holdings, a Portfolio Company Preparing to Commence Mining Operations in South Africa

QLGN: Dosing Begins in Phase 1 Trial of QN-302…
QLGN

Zacks Small Cap Research

a year ago

QLGN: Dosing Begins in Phase 1 Trial of QN-302…

Royalty Management and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
QLGN

ACCESSWIRE

a year ago

Royalty Management and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

The past five years for MediciNova (NASDAQ:MNOV) investors has not been profitable
QLGN

Simply Wall St.

a year ago

The past five years for MediciNova (NASDAQ:MNOV) investors has not been profitable

QLGN

Business Wire

a year ago

Cyclo Therapeutics Reports Third Quarter 2023 Financial Results

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023
QLGN

GlobeNewswire

a year ago

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023

BETTER CHOICE COMPANY, INC. ANNOUNCES THIRD QUARTER 2023 RESULTS
QLGN

GlobeNewswire

a year ago

BETTER CHOICE COMPANY, INC. ANNOUNCES THIRD QUARTER 2023 RESULTS

UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
QLGN

GlobeNewswire

a year ago

UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

Wilhelmina International, Inc. Reports Results for Third Quarter 2023
QLGN

GlobeNewswire

a year ago

Wilhelmina International, Inc. Reports Results for Third Quarter 2023

SuRo Capital Corp. (NASDAQ:SSSS) Q3 2023 Earnings Call Transcript
QLGN

Insider Monkey

a year ago

SuRo Capital Corp. (NASDAQ:SSSS) Q3 2023 Earnings Call Transcript

QLGN

Business Wire

a year ago

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

Verano Holdings Corp. (VRNOF) Reports Q3 Loss, Lags Revenue Estimates
QLGN

Zacks

a year ago

Verano Holdings Corp. (VRNOF) Reports Q3 Loss, Lags Revenue Estimates

Israeli Ministry of Health Reports Surge in Medical Cannabis Patients Following Recent Events
QLGN

GlobeNewswire

a year ago

Israeli Ministry of Health Reports Surge in Medical Cannabis Patients Following Recent Events

Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors
QLGN

GlobeNewswire

a year ago

Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors

Immunic to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide Corporate Update
QLGN

PR Newswire

a year ago

Immunic to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide Corporate Update

QLGN

Thomson Reuters StreetEvents

a year ago

Q3 2023 Cooper-Standard Holdings Inc Earnings Call

Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to December 3, 2023
QLGN

GlobeNewswire

a year ago

Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to December 3, 2023

Cooper-Standard Holdings Inc (CPS) Reports 12% Sales Increase and 176. ...
QLGN

GuruFocus.com

a year ago

Cooper-Standard Holdings Inc (CPS) Reports 12% Sales Increase and 176. ...

QLGN

Thomson Reuters StreetEvents

a year ago

Q3 2023 Natural Health Trends Corp Earnings Call

QLGN

GuruFocus.com

a year ago

Natural Health Trends Corp (NHTC) Reports Q3 2023 Earnings: Cash Flows Improve by $1.4 Million

QLGN

Associated Press Finance

a year ago

Natural Health Trends: Q3 Earnings Snapshot

Natural Health Trends Reports Third Quarter 2023 Financial Results
QLGN

GlobeNewswire

a year ago

Natural Health Trends Reports Third Quarter 2023 Financial Results

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
QLGN

GlobeNewswire

a year ago

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results

Share on Social Networks: